The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Menzel Garry E since 2021.
This trader's CIK number is 1556064.
At the time of last reporting, Menzel Garry E was the Officer of Adaptimmune Therapeutics Plc. (stock ticker symbol ADAP).
Also see all insider trading activities at Adaptimmune Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ADAP | 0 | $0 | 47,702 | $43,456 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | TCRR | 0 | $0 | 63,762 | $78,504 | 221,058 | $0 |
| 2021 | TCRR | 0 | $0 | 0 | $0 | 175,000 | $129,500 |
1. Adaptimmune Therapeutics Plc (ADAP)
2. Tcr2 Therapeutics Inc. (TCRR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-10 | ADAP | Sale | 47,702 | .91 | 43,456 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-09 | TCRR | Sale | 10,325 | 1.13 | 11,677 |
| 2022-12-13 | TCRR | Sale | 11,000 | 1.06 | 11,682 |
| 2022-12-12 | TCRR | Sale | 10,613 | 1.10 | 11,674 |
| 2022-12-06 | TCRR | Sale | 14,886 | 1.35 | 20,081 |
| 2022-12-05 | TCRR | Sale | 8,530 | 1.37 | 11,703 |
| 2022-12-01 | TCRR | Option Ex | 221,058 | .00 | 0 |
| 2022-12-02 | TCRR | Sale | 8,408 | 1.39 | 11,687 |
| 2021-12-09 | TCRR | Option Ex | 175,000 | .74 | 129,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Menzel Garry E (Officer of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.